Bodenstedt Matthias (CIK 1920545) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-23). Recent activity: Sell MLTX (39,120 shares), Sell MLTX (15,082 shares), Sell MLTX (2,794 shares), Sell MLTX (13,653 shares), Sell MLTX (2,426 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-23 | MoonLake Immunotherapeutics (MLTX) | Chief Financial Officer | Sell | 39,120 | $862,205 |
| 2026-06-18 | MoonLake Immunotherapeutics (MLTX) | Chief Financial Officer | Sell | 15,082 | $296,814 |
| 2026-06-18 | MoonLake Immunotherapeutics (MLTX) | Chief Financial Officer | Sell | 2,794 | $54,762 |
| 2026-05-13 | MoonLake Immunotherapeutics (MLTX) | Chief Financial Officer | Sell | 13,653 | $273,333 |
| 2026-04-16 | MoonLake Immunotherapeutics (MLTX) | Chief Financial Officer | Sell | 2,426 | $47,453 |
| 2026-04-10 | MoonLake Immunotherapeutics (MLTX) | Chief Financial Officer | Sell | 85,870 | $1.6M |
| 2026-04-10 | MoonLake Immunotherapeutics (MLTX) | Chief Financial Officer | Sell | 1,925 | $37,557 |
| 2026-01-09 | MoonLake Immunotherapeutics (MLTX) | Chief Financial Officer | Buy | 354,296 | $0 |
| 2025-12-22 | MoonLake Immunotherapeutics (MLTX) | Chief Financial Officer | Buy | 294,473 | $0 |
| 2025-12-22 | MoonLake Immunotherapeutics (MLTX) | Chief Financial Officer | Sell | 294,473 | $0 |
| 2025-10-09 | MoonLake Immunotherapeutics (MLTX) | Chief Financial Officer | Buy | 10,870 | $98,808 |
| 2025-03-03 | MoonLake Immunotherapeutics (MLTX) | Chief Financial Officer | Buy | 95,763 | $0 |
Source: SEC Form 4 filings · as of 2026-06-23